Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I. Silverberg, Raj Chovatiya, Thomas Bieber et al.|Dermatology and Therapy|2025Cited by 24
Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized StudiesGil Yosipovitch, Thomas A. Luger, Toby Kent et al.|Dermatology and Therapy|2018Cited by 23